HHS - G2 Intelligence

Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs)

Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs)

by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, Coronavirus, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

FDA Imposes New Limits on COVID-19 Tests with Access to EUA Pathway

FDA Imposes New Limits on COVID-19 Tests with Access to EUA Pathway

by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

HHS to FDA: Resume EUA Review of COVID-19 LDTs, And Do It Fast

by Glenn S. Demby | Dec 1, 2020 | Articles, Essential, Industry Buzz-lir, Inside the Lab Industry-lir, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Labs to HHS: Since We Can’t COVID-19 Test Everyone, Let Us Prioritize the Symptomatic

by Glenn S. Demby | Sep 4, 2020 | Articles, National Lab Reporter

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Give Labs the Money They Need to Develop COVID-19 Testing Capacity

by Glenn S. Demby | Jun 17, 2020 | Articles, Essential, Funding-nir, National Lab Reporter

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

« Older Entries

Next Entries »